CD8A and nonpapillary renal cell carcinoma: Multimodal digital spatial molecular analysis identified that patients with Stage III ccRCC who received pre-operative ICI had increased intratumoral expression of genes and protein products indicative of CD8+ T-cell effector and central-memory phenotypes – similar to untreated patients who did not recur after surgery.